These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 11244515)

  • 61. Commentary on the Carvedilol or Metoprolol European Trial (COMET).
    Poole-Wilson PA
    Am J Cardiol; 2004 May; 93(9A):40B-2B. PubMed ID: 15144936
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Beta-blockers in heart failure. Do they improve the quality as well as the quantity of life?
    Fowler MB
    Eur Heart J; 1998 Dec; 19 Suppl P():P17-25. PubMed ID: 9886708
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Landmark studies: the Australia/New Zealand Heart Failure Collaborative Group (ANZ) Trial and the US Carvedilol Trials Program.
    Gilbert EM
    Am J Cardiol; 2004 May; 93(9A):30B-4B. PubMed ID: 15144934
    [TBL] [Abstract][Full Text] [Related]  

  • 64. New evidence from the CAPRICORN Trial: the role of carvedilol in high-risk, post-myocardial infarction patients.
    Sackner-Bernstein JD
    Rev Cardiovasc Med; 2003; 4 Suppl 3():S25-9. PubMed ID: 14564231
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Current status of rotational atherectomy.
    Cavusoglu E; Kini AS; Marmur JD; Sharma SK
    Catheter Cardiovasc Interv; 2004 Aug; 62(4):485-98. PubMed ID: 15274159
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Transluminal extraction coronary atherectomy.
    Annex BH; Sketch MH; Stack RS; Phillips HR
    Cardiol Clin; 1994 Nov; 12(4):611-22. PubMed ID: 7850832
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Critical differences among beta-adrenoreceptor antagonists in myocardial failure: debating the MERIT of COMET.
    McBride BF; White CM
    J Clin Pharmacol; 2005 Jan; 45(1):6-24. PubMed ID: 15601801
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Coronary artery disease and antioxidants--is there a role for carvedilol?
    Landray MJ; Kendall MJ
    J Clin Pharm Ther; 1997 Feb; 22(1):3-5. PubMed ID: 9292396
    [No Abstract]   [Full Text] [Related]  

  • 69. Further insights into coronary debulking: the EUROCARE trial of directional atherectomy and the PACT trial of pullback atherectomy.
    Thury A; Van Langenhove G; Wardeh AJ; Foley DP; Serruys PW
    Semin Interv Cardiol; 2000 Dec; 5(4):185-92. PubMed ID: 11244515
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Directional coronary atherectomy in 2005.
    Repetto A; Ferlini M; Ferrario M; Angoli L; Bramucci E
    Ital Heart J; 2005 Jun; 6(6):494-7. PubMed ID: 16008154
    [TBL] [Abstract][Full Text] [Related]  

  • 71. [Role of atherectomy devices in interventional cardiology].
    Dill T; Vom Dahl J
    Herz; 2002 Sep; 27(6):502-7. PubMed ID: 12378394
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Atherectomy (directional, rotational, extractional) and its role in percutaneous revascularization.
    Kaufmann UP; Meyer BJ
    Curr Opin Cardiol; 1995 Jul; 10(4):412-9. PubMed ID: 7549084
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Role of carvedilol in atrial fibrillation: insights from clinical trials.
    Gheorghiade M; Lukas MA
    Am J Cardiol; 2004 May; 93(9A):53B-7B. PubMed ID: 15144939
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Directional coronary atherectomy: from therapeutic device to research tool in coronary artery disease.
    Di Sciascio G; Patti G
    Cardiologia; 1999 Apr; 44(4):333-9. PubMed ID: 10371784
    [TBL] [Abstract][Full Text] [Related]  

  • 75.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 76.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 77.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 78.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 79.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]     [New Search]
    of 4.